# Avalanche Treasury Corp: financial statements, quarterly

AVAT · Nasdaq · CIK 2092446 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/avat.md) · [Financials](/companies/avat/financials.md) · [Filings](/companies/avat/filings.md) · [Insiders](/companies/avat/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/avat/financials.md?period=annual).

## Income statement

| Line item | Unit | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: |
| Revenue | $m | [0.0](/filings/0001104659-26-078841.md) | [1.5](/filings/0001104659-26-098819.md) |
| Operating income | $m | not reported | [(52.9)](/filings/0001104659-26-098819.md) |
| Interest expense | $m | not reported | [0.1](/filings/0001104659-26-098819.md) |
| Net income | $m | [(26.8)](/filings/0001104659-26-098819.md) | [(44.7)](/filings/0001104659-26-098819.md) |
| Diluted EPS | $ per share | [(139.64)](/filings/0001104659-26-078841.md) | [(1.54)](/filings/0001104659-26-098819.md) |
| Basic EPS | $ per share | [(139.64)](/filings/0001104659-26-078841.md) | [(1.54)](/filings/0001104659-26-098819.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | period not labelled (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: |
| Cash and equivalents | $m | [0.0](/filings/0001104659-26-078841.md) | [0.0](/filings/0001104659-26-078841.md) | [3.4](/filings/0001104659-26-098819.md) |
| Current assets | $m | [8.5](/filings/0001104659-26-098819.md) | [2.2](/filings/0001104659-26-078841.md) | [28.1](/filings/0001104659-26-098819.md) |
| Total assets | $m | [191](/filings/0001104659-26-098819.md) | [2.2](/filings/0001104659-26-078841.md) | [109](/filings/0001104659-26-098819.md) |
| Current liabilities | $m | [1.8](/filings/0001104659-26-078841.md) | [2.5](/filings/0001104659-26-078841.md) | not reported |
| Total liabilities | $m | [40.5](/filings/0001104659-26-098819.md) | [2.5](/filings/0001104659-26-078841.md) | [25.3](/filings/0001104659-26-098819.md) |
| Shareholders' equity | $m | [150](/filings/0001104659-26-098819.md) | [124](/filings/0001104659-26-098819.md) | [83.8](/filings/0001104659-26-098819.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue, us-gaap:Cash
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Shares

| Line item | Unit | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [0.0](/filings/0001104659-26-078841.md) | [29.1](/filings/0001104659-26-098819.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:51 ET. No prices; not investment advice.